TUMOR METASTASIS INHIBITOR

Title:

TUMOR METASTASIS INHIBITOR

Document Type and Number:

Japanese Patent JPH07196490

Kind Code:

A

Abstract:

PURPOSE: To obtain a cancer metastasis inhibitor which contains baicalein as an active ingredient and shows excellent a α-glucosidase inhibitory action and cancerous cells invasion inhibitory action.

CONSTITUTION: The tumor metastasis inhibitor contains baicalein, namely 5,6,7- trihydroxy-2-phenyl-4H-1-benzopyran-4-one, as an active ingredient. The dose of the metastasis inhibitor is preferably 0.01 to 100mg/kg body weight/day in adult. Baicalein is isolated from a tropical plant, Oloxyrum indicum.

More Like This:

WO/2017/156520	ICARIIN AND ICARITIN DERIVATIVES
JP4431638	Dihydropyridines-, pyridines-, benzopyran-ones and triazoloquinazoline derivatives, their production and their use as adenosine receptor antagonists
JP5534751	Androgen receptor antagonists and androgen receptor binding inhibitors

Inventors:

UMEZAWA KAZUO
KOYANO TAKASHI
TAKAHASHI KEIMEI
YAMAMOTO TAKASHI

Application Number:

JP35287593A

Publication Date:

August 01, 1995

Filing Date:

December 28, 1993

Export Citation:

Click for automatic bibliography generation Help

Assignee:

TERUMO CORP
UMEZAWA KAZUO

International Classes:

C07D311/30; A61K31/35; A61K31/352; A61P35/00; A61P43/00; (IPC1-7): A61K31/35; A61K31/35; C07D311/30

Attorney, Agent or Firm:

Shoichi Mukaiyama

Previous Patent: Optimization Problem Calculation Program, Optimization Problem Calculation Method, and Optimization ...

Next Patent: Liquid ejection head and device for ejecting liquid